menu ☰
menu ˟

Givosiran offers hope for acute hepatic porphyria recurrent attacks

13 Apr 2019
VIENNA — An “exciting, novel RNAi therapy” significantly lowered acute hepatic porphyria recurrent attacks, according to data presented during the International Liver Congress 2019.“Fifty percent of the givosiran patients were attack-free for...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.